At the completion of this CME teaching activity, you should be able to:

• Utilize the WHO terminology and histologic and molecular features for a variety of mesenchymal gynecologic tumors.
• Recognize the features that distinguish borderline ovarian tumors from carcinoma.
• Assess hormonally treated endometrial carcinomas and predict responsiveness to treatment.
• Recognize the different subtypes of endometrial cancers.
• Recognize variant morphologies of the most common mesenchymal tumors of the uterus.
• Distinguish adenocarcinoma in-situ (AIS) from benign mimickers.

Topics/Speakers: 

• Staging Endometrioid Adenocarcinoma: Pitfalls and Pearls
  Charles Matthew Quick, M.D.
• Endocervical Glandular Lesions: Changes on the Horizon
  Charles Matthew Quick, M.D.
• Squamous Dysplasia: Two Take Home Points
  Charles Matthew Quick, M.D.
• Biomarkers in the Uterine Cervix: What to Use and When to Use It
  Anne M. Mills, M.D.
• Evaluating Endometrial Carcinoma in the Molecular Age: From Type I/II to TGCA
  Anne M. Mills, M.D.
• From Lynch Syndrome to Immunotherapy: Mismatch Repair in the Gynecologic Tract
  Anne M. Mills, M.D.
• Precursors of Endometrioid Adenocarcinoma
  Jennifer A. Brainard, M.D.
• Endometrioid Endometrial Adenocarcinoma: Variants, Selected Challenges and Molecular Features
  Jennifer A. Brainard, M.D.
• Unraveling the Mesenchymal Madness in Gynecologic Tumors
  Kristen A. Atkins, M.D.
• Is it Borderline or Carcinoma? Teasing out the Challenging Ovarian Epithelial Tumors
  Kristen A. Atkins, M.D.
• Endometrial Neoplasia in Young Women
  Kristen A. Atkins, M.D.